Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of wnt signaling in renal cancer

Journal of Biological Chemistry

Volumn 288, Issue 36, 2013, Pages 26301-26310

  Rasmussen, Neal R ^a   Wright, Tricia M ^a   Brooks, Samira A ^a   Hacker, Kathryn E ^a   Debebe, Zufan ^a   Sendor, Adam B ^a   Walker, Matthew P ^a   Major, Michael Ben ^a,b   Green, Jennifer ^c   Wahl, Geoffrey M ^c   Rathmell, W Kimryn ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANONICAL WNT SIGNALING; CATENIN SIGNALING; RENAL CANCERS; TUMORIGENICITY; WNT SIGNALING;

AMINO ACIDS; LIGANDS;

CELL SIGNALING;

BETA CATENIN; DICKKOPF PROTEIN; GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR2 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE TARGETING; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; WNT SIGNALING PATHWAY;

Β-CATENIN; CANCER; RCC; RECEPTOR TYROSINE KINASE; RENAL CELL CARCINOMA; ROR2; SIGNALING; WNT SIGNALING; WNT3A;

AXIN PROTEIN; BETA CATENIN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; NEOPLASM PROTEINS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84883686303     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.466086     Document Type: Article

References (34)

1. Majid, S., Saini, S., and Dahiya, R. (2012) Wnt signaling pathways in urological cancers. Past decades and still growing. Mol. Cancer 11, 7
2. Li, V. S., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J., Maurice, M. M., Mahmoudi, T., and Clevers, H. (2012) Wnt signaling through inhibition of-catenin degradation in an intact Axin1 complex. Cell 149, 1245-1256
3. Angers, S., and Moon, R. T. (2009) Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10, 468-477
4. Wright, T. M., Brannon, A. R., Gordan, J. D., Mikels, A. J., Mitchell, C., Chen, S., Espinosa, I., van de Rijn, M., Pruthi, R., Wallen, E., Edwards, L., Nusse, R., and Rathmell, W. K. (2009) Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene 28, 2513-2523
5. Edris, B., Espinosa, I., Mühlenberg, T., Mikels, A., Lee, C. H., Steigen, S. E., Zhu, S., Montgomery, K. D., Lazar, A. J., Lev, D., Fletcher, J. A., Beck, A. H., West, R. B., Nusse, R., and van de Rijn, M. (2012) ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J. Pathol. 227, 223-233
6. Lu, B. J., Wang, Y. Q., Wei, X. J., Rong, L. Q., Wei, D., Yan, C. M., Wang, D. J., and Sun, J. Y. (2012) Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma. Mol. Med. Rep. 5, 1033-1036
7. O'Connell, M. P., Fiori, J. L., Xu, M., Carter, A. D., Frank, B. P., Camilli, T. C., French, A. D., Dissanayake, S. K., Indig, F. E., Bernier, M., Taub, D. D., Hewitt, S. M., and Weeraratna, A. T. (2010) The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 29, 34-44
8. Kobayashi, M., Shibuya, Y., Takeuchi, J., Murata, M., Suzuki, H., Yokoo, S., Umeda, M., Minami, Y., and Komori, T. (2009) Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 107, 398-406
9. Yamamoto, H., Oue, N., Sato, A., Hasegawa, Y., Yamamoto H., Matsubara, A., Yasui, W., and Kikuchi, A. (2010) Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29, 2036-2046
10. Wright, T. M., and Rathmell, W. K. (2010) Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma. J. Biol. Chem. 285, 12916-12924
11. Takeuchi, S., Takeda, K., Oishi, I., Nomi, M., Ikeya, M., Itoh, K., Tamura, S., Ueda, T., Hatta, T., Otani, H., Terashima, T., Takada, S., Yamamura, H., Akira, S., and Minami, Y. (2000) Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells 5, 71-78
12. Afzal, A. R., Rajab, A., Fenske, C. D., Oldridge, M., Elanko, N., Ternes- Pereira, E., Tüysüz, B., Murday, V. A., Patton, M. A., Wilkie, A. O., and Jeffery, S. (2000) Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat. Genet. 25, 419-422
13. Oldridge, M., Fortuna, A. M., Maringa, M., Propping, P., Mansour, S., Pollitt, C., DeChiara, T. M., Kimble, R. B., Valenzuela, D. M., Yancopoulos, G. D., and Wilkie, A. O. (2000) Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat. Genet. 24, 275-278
14. Al-Shawi, R., Ashton, S. V., Underwood, C., and Simons, J. P. (2001) Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev. Genes Evol. 211, 161-171
15. Matsuda, T., Nomi, M., Ikeya, M., Kani, S., Oishi, I., Terashima, T., Takada, S., and Minami, Y. (2001) Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. Mech. Dev. 105, 153-156
16. Li, C., Chen, H., Hu, L., Xing, Y., Sasaki, T., Villosis, M. F., Li, J., Nishita, M., Minami, Y., and Minoo, P. (2008) Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2.BMCMol. Biol. 9, 11
17. Billiard, J., Way, D. S., Seestaller-Wehr, L. M., Moran, R. A., Mangine, A., and Bodine, P. V. (2005) The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells. Mol. Endocrinol. 19, 90-101
18. Mikels, A. J., and Nusse, R. (2006) Purified Wnt5a protein activates or inhibits -catenin-TCF signaling depending on receptor context. PLoS Biol. 4, e115
19. Laird, D. J., Altshuler-Keylin, S., Kissner, M. D., Zhou, X., and Anderson, K. V. (2011) Ror2 enhances polarity and directional migration of primordial germ cells. PLoS Genet. 7, e1002428
20. Schambony, A., and Wedlich, D. (2007) Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev. Cell 12, 779-792
21. Ho, H. Y., Susman, M. W., Bikoff, J. B., Ryu, Y. K., Jonas, A. M., Hu, L., Kuruvilla, R., and Greenberg, M. E. (2012) Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 109, 4044-4051
22. Choi, H., Chun, Y. S., Kim, T. Y., and Park, J. W. (2010) HIF-2 enhances -catenin/TCF-driven transcription by interacting with catenin. Cancer Res. 70, 10101-10111
23. Chitalia, V. C., Foy, R. L., Bachschmid, M. M., Zeng, L., Panchenko, M. V., Zhou, M. I., Bharti, A., Seldin, D. C., Lecker, S. H., Dominguez, I., and Cohen, H. T. (2008) Jade-1 inhibits Wnt signalling by ubiquitylating -catenin and mediates Wnt pathway inhibition by pVHL. Nat. Cell Biol. 10, 1208-1216
24. Peruzzi, B., Athauda, G., and Bottaro, D. P. (2006) The von Hippel-Lindau tumor suppressor gene product represses oncogenic -catenin signaling in renal carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 103, 14531-14536
25. Iliopoulos, O., Kibel, A., Gray, S., and Kaelin, W. G., Jr. (1995) Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1, 822-826
26. Angers, S., Thorpe, C. J., Biechele, T. L., Goldenberg, S. J., Zheng, N., MacCoss, M. J., and Moon, R. T. (2006) The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-catenin pathway by targeting Dishevelled for degradation. Nat. Cell Biol. 8, 348-357
27. O'Connell, R. M., Balazs, A. B., Rao, D. S., Kivork, C., Yang, L., and Baltimore, D. (2010) Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS ONE 5, e12009
28. Teng, B. L., Hacker, K. E., Chen, S., Means, A. R., and Rathmell, W. K. (2011) Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma. Mol. Oncol. 5, 465-474
29. Mikels, A., Minami, Y., and Nusse, R. (2009) Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J. Biol. Chem. 284, 30167-30176
30. Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., and Skarnes, W. C. (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407, 535-538
31. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J. P., and He, X. (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407, 530-535
32. Yamagata, K., Li, X., Ikegaki, S., Oneyama, C., Okada, M., Nishita, M., and Minami, Y. (2012) Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. J. Biol. Chem. 287, 1588-1599
33. Nishita, M., Itsukushima, S., Nomachi, A., Endo, M., Wang, Z., Inaba, D., Qiao, S., Takada, S., Kikuchi, A., and Minami, Y. (2010) Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Mol. Cell Biol. 30, 3610-3619
34. Hsu, R. J., Ho, J. Y., Cha, T. L., Yu, D. S., Wu, C. L., Huang, W. P., Chu, P., Chen, Y. H., Chen, J. T., and Yu, C. P. (2012) WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/-catenin pathway. PLoS ONE 7, e47649